Federal Register / Vol. 71, No.
116 / Friday, June 16, 2006 / Notices
patent term under 35 U.S.C. 156(d)(5) is
appropriate.
A third interim extension under 35
U.S.C. 156(d)(5) of the term of U.S.
Patent No. 4,591,585 is granted for a
period of one year from the expiration
date of the patent, i.e., until June 18,
2007.
Dated: June 12, 2006.
Jon W. Dudas
Under Secretary of Commerce for Intellectual
Property and Director of the United States
Patent and Trademark Office.
[FR Doc. E6–9489 Filed 6–15–06; 8:45 am]
BILLING CODE 3510–16–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No. PTO–P–2006–0033]
Grant of Interim Extension of the Term
of U.S. Patent No. 4,585,597;
ANTHÉLIOS SP (HELIOBLOCK SX
Cream) (Mexoryl SX (Ecamsule))
AGENCY: United States Patent and
Trademark Office, Commerce.
ACTION: Notice of Interim Patent Term
Extension.
SUMMARY: The United States Patent and
Trademark Office has issued a
certificate under 35 U.S.C. 156(d)(5) for
a fourth one-year interim extension of
the term of U.S. Patent No. 4,585,597.
FOR FURTHER INFORMATION CONTACT:
Mary C. Till by telephone at (571) 272–
7755; by mail marked to her attention
and addressed to the Commissioner for
Patents, Mail Stop Patent Ext., P.O. Box
1450, Alexandria, VA 22313–1450; by
fax marked to her attention at (571) 273–
7755, or by e-mail to
Mary.Till@uspto.gov.
SUPPLEMENTARY INFORMATION: Section
156 of Title 35, United States Code,
generally provides that the term of a
patent may be extended for a period of
up to five years if the patent claims a
product, or a method of making or using
a product, that has been subject to
certain defined regulatory review, and
that the patent may be extended for
interim periods of up to a year if the
regulatory review is anticipated to
extend beyond the expiration date of the
patent.
On May 16, 2006, patent owner, L
Oreal S.A., timely filed an application
under 35 U.S.C. 156(d)(5) for a fourth
subsequent interim extension of the
wwhite on PROD1PC61 with NOTICES
term of U.S. Patent No. 4,585,597. The
patent claims the active ingredient
Mexoryl SX (ecamsule), in the human
drug product ANTHELIOS SP
(HELIOBLOCK SX Cream), a method of
VerDate Aug<31>2005 18:25 Jun 15, 2006 Jkt 208001
34897
use of the active ingredient, and a
method of manufacturing the active
ingredient. The application indicates,
and the Food and Drug Administration
has confirmed, that a New Drug
Application for the human drug product
Mexoryl SX (ecamsule) has been filed
and is currently undergoing regulatory
review before the Food and Drug
Administration for permission to market
or use the product commercially.
Review of the application indicates
that, except for permission to market or
use the product commercially, the
subject patent would be eligible for an
extension of the patent term under 35
U.S.C. 156, and that the patent should
be extended for an additional year as
required by 35 U.S.C. 156(d)(5)(B).
Because it is apparent that the
regulatory review period will continue
beyond the extended expiration date of
the patent (June 16, 2006), interim
extension of the patent term under 35
U.S.C. 156(d)(5) is appropriate. A fourth
interim extension under 35 U.S.C.
156(d)(5) of the term of U.S. Patent No.
4,585,597 is granted for a period of one
year from the extended expiration date
of the patent, i.e., until June 16, 2007.
Dated: June 12, 2006.
Jon W. Dudas,
Under Secretary of Commerce for Intellectual
Property and Director of the United States
Patent and Trademark Office.
[FR Doc. E6–9490 Filed 6–15–06; 8:45 am]
BILLING CODE 3510–16–P
DEPARTMENT OF COMMERCE
Patent and Trademark Office
[Docket No. PTO–P–2006–0019]
Grant of Interim Extension of the Term
of U.S. Patent No. 4,850,962; Esteem
(Totally Implantable Hearing System)
AGENCY: United States Patent and
Trademark Office, Commerce.
ACTION: Notice of Interim Patent Term
Extension.
SUMMARY: The United States Patent and
Trademark Office has issued a
certificate under 35 U.S.C. 156(d)(5) for
a one-year interim extension of the term
of U.S. Patent No. 4,850,962.
FOR FURTHER INFORMATION CONTACT:
Mary C. Till by telephone at (571) 272–
7755; by mail marked to her attention
and addressed to the Commissioner for
Patents, Mail Stop Patent Ext., P.O. Box
1450, Alexandria, VA 22313–1450; by
fax marked to her attention at (571) 273–
7755, or by e-mail to
Mary.Till@uspto.gov.
PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 E:\FR\FM\16JNN1.SGM
SUPPLEMENTARY INFORMATION: Section
156 of Title 35, United States Code,
generally provides that the term of a
patent may be extended for a period of
up to five years if the patent claims a
product, or a method of making or using
a product, that has been subject to
certain defined regulatory review, and
that the patent may be extended for
interim periods of up to a year if the
regulatory review is anticipated to
extend beyond the expiration date of the
patent.
On March 31, 2006, patent owner,
Envoy Medical Corporation, timely filed
an application under 35 U.S.C. 156(d)(5)
for an interim extension of the term of
U.S. Patent No. 4,850,962. The patent
claims the medical device Esteem
(totally implantable hearing system).
The application indicates that an
Investigational Device Exemption for
the medical device Esteem has been
filed and is currently undergoing
regulatory review before the Food and
Drug Administration for permission to
market or use the product commercially.
Review of the application indicates
that except for permission to market or
use the product commercially, the
subject patent would be eligible for an
extension of the patent term under 35
U.S.C. 156, and that the patent should
be extended for one year as required by
35 U.S.C. 156(d)(5)(B). Because it is
apparent that the regulatory review
period will continue beyond the original
expiration date of the patent (July 25,
2006), interim extension of the patent
term under 35 U.S.C. 156(d)(5) is
appropriate.
An interim extension under 35 U.S.C.
156(d)(5) of the term of U.S. Patent No.
4,850,962 is granted for a period of one
year from the original expiration date of
the patent, i.e., until July 25, 2007.
Dated: June 12, 2006.
Jon W. Dudas,
Under Secretary of Commerce for Intellectual
Property and Director of the United States
Patent and Trademark Office.
[FR Doc. E6–9494 Filed 6–15–06; 8:45 am]
BILLING CODE 3510–16–P
COMMODITY FUTURES TRADING
COMMISSION
Sunshine Act Meeting
TIME AND DATE: 11 a.m., Friday, July 7,
2006.
PLACE: 1155 21st St., NW., Washington,
DC, 9th Floor Commission Conference
Room.
STATUS: Closed.
MATTERS TO BE CONSIDERED: Surveillance
Matters.
16JNN1
 34898 Federal Register / Vol. 71, No. 116 / Friday, June 16, 2006 / Notices

FOR FURTHER INFORMATION CONTACT: FOR FURTHER INFORMATION CONTACT:
Eileen A. Donovan, 202–418–5100. Eileen A. Donovan, 202–418–5100.
Eileen A. Donovan, Eileen A. Donovan,
Acting Secretary of the Commission. Acting Secretary of the Commission.
[FR Doc. 06–5518 Filed 6–14–06; 1:32 pm] [FR Doc. 06–5521 Filed 6–14–06; 1:32 pm]
BILLING CODE 6351–01–M BILLING CODE 6351–01–M
COMMODITY FUTURES TRADING
DEPARTMENT OF DEFENSE
COMMISSION
[DOD–2006–OS–0121]
Sunshine Act Meeting
Defense Finance and Accounting
TIME AND DATE: 11 a.m., Friday, July 28, Service; Privacy Act of 1974; Systems
2006. of Records
PLACE: 1155 21st St., NW., Washington, AGENCY: Defense Finance and
DC, 9th Floor Commission Conference Accounting Service.
Room. ACTION: Notice to add a new system of
records.
STATUS: Closed.
MATTERS TO BE CONSIDERED: Surveillance SUMMARY: The Defense Finance and
Matters. Accounting Service (DFAS) is proposing
to add a system of records notice to its
FOR FURTHER INFORMATION CONTACT: inventory of record systems subject to
Eileen A. Donovan, 202–418–5100. the Privacy Act of 1974, (5 U.S.C. 552a),
Eileen A. Donovan, as amended.
Acting Secretary of the Commission. DATES: This Action will be effective
without further notice on July 17, 2006
[FR Doc. 06–5519 Filed 6–14–06; 1:32 pm]
BILLING CODE 6351–01–M
unless comments are received that
would result in a contrary
determination.
COMMODITY FUTURES TRADING ADDRESSES: Send comments to the
COMMISSION FOIA/PA Program Manager, Corporate
Communications and Legislative
Sunshine Act Meeting Liaison, Defense Finance and
Accounting Service, 6760 E. Irvington
TIME AND DATE: 11 a.m., Friday, July 21, Place, Denver, CO 90279–8000.
2006.
FOR FURTHER INFORMATION CONTACT: Ms.
PLACE: 1155 21st St., NW., Washington, Linda Krabbenhoft at (303) 676–6045.
DC, 9th Floor Commission Conference
SUPPLEMENTARY INFORMATION: The
Room.
Defense Finance and Accounting
STATUS: Closed. Service notices for systems of records
subject to the Privacy Act of 1974 (5
MATTERS TO BE CONSIDERED: U.S.C. 552a), as amended, have been
Enforcement Matters. published in the Federal Register and
FOR FURTHER INFORMATION CONTACT: are available from the address above.
Eileen A Donovan, 202–418–5100. The proposed system report, as
required by 5 U.S.C. 552a(r) of the
Eileen A. Donovan,
Privacy Act of 1974, as amended, was
Acting Secretary of the Commission. submitted on June 6, 2006, to the House
[FR Doc. 06–5520 Filed 6–14–06; 8:45 am] Committee on Government Reform, the
BILLING CODE 6351–01–M Senate Committee on Governmental
Affairs, and the Office of Management
and Budget (OMB) pursuant to
COMMODITY FUTURES TRADING paragraph 4c of Appendix I to OMB
COMMISSION Circular No. A–130, ‘‘Federal Agency
Responsibilities for Maintaining
Sunshine Act Meeting
Records About Individuals,’’ dated
December 12, 2000, 65 FR 239.
TIME AND DATE: 11 a.m., Friday, July 14,
2006. Dated: June 12, 2006.
C.R. Choate,
PLACE: 1155 21st St., NW., Washington,
DC., 9th Floor Commission Conference Alternate OSD Federal Register Liaison
wwhite on PROD1PC61 with NOTICES
SYSTEM LOCATION:
Defense Finance and Accounting
Service—Cleveland, 1240 East Ninth
Street, Cleveland, OH 44199.
Office of Personnel Management,
4685 Log Cabin Drive, Macon, GA
31204–6317.
CATEGORIES OF INDIVIDUALS COVERED BY THE
SYSTEM:
Active Duty and Reserve military
personnel, members of the National
Guard, military academy cadets, Naval
Reserve Officer Training Corps students,
and Armed Forces Health Professions
Scholarship Program (AFHPSP)
students.
All DoD civilian employees paid by
appropriated funds.
All Army nonappropriated fund
instrumentalities employees paid by
nonappropriated funds.
Military retirees, their former spouses
(Former Spouse Protection Act (FSPA)
Claimants), and annuitants.
Executive Office of the President
employees.
Department of Health and Human
Services employees.
Department of Energy employees.
CATEGORIES OF RECORDS IN THE SYSTEM:
Individual’s Name, Social Security
Number, employing DoD and other
Federal agencies, military branch of
service, status (as appropriate), and e-
mail addresses are maintained in the
Master PIN Database (MPDB).
AUTHORITY FOR MAINTENANCE OF THE SYSTEM:
5 U.S.C. 301, Departmental
Regulations; 5 U.S.C. Chapter 53, 55,
and 81; and E.O. 9397 (SSN).
PURPOSE(S):
The MyPay System is a combination
Internet (WEB) based and interactive
voice response telephonic system (IVRS)
designed to allow authorized
individuals the ability to retrieve,
review and update payroll information
from their specific payroll system(s).
Records are also used for extraction or
compilation of data and reports for
management studies and statistical
analyses for use internally or externally
as required by DoD or other government
agencies.
ROUTINE USES OF RECORDS MAINTAINED IN THE
SYSTEM, INCLUDING CATEGORIES OF USERS AND
THE PURPOSES OF SUCH USES:
In addition to those disclosures
generally permitted under 5 U.S.C.
552a(b) of the Privacy Act, these records
or information contained therein may

Officer, Department of Defense. specifically be disclosed outside the

Room.
T7336 DoD as a routine use pursuant to 5
STATUS: Closed. U.S.C. 552a(b)(3) as follows:
MATTERS TO BE CONSIDERED: Surveillance SYSTEM NAME: To Federal, State, and local agencies
Matters. MyPay System. for the purpose of conducting computer

VerDate Aug<31>2005 18:25 Jun 15, 2006 Jkt 208001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 E:\FR\FM\16JNN1.SGM 16JNN1